@Doctor_Beryl profile picture
Beryl Manning-Geist, MD @Doctor_Beryl

Emory SOM Faculty | Memorial Sloan Kettering Gynecologic Oncology Fellow | Harvard OB-GYN | Views are my own

Joined March 2020
  • Tweets 250
  • Following 309
  • Followers 775
54 Photos and videos
A privilege to provide commentary in @gynoncjnls on how we leverage the folate receptor to treat gynecologic malignancy. It’s time to outsmart cancer! @WinshipAtEmory pubmed.ncbi.nlm.nih.gov/3966…

Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian...

Following the folate receptor: Expanding targeted treatment options in low grade serous ovarian carcinoma

pubmed.ncbi.nlm.nih.gov
6
15
1,366
It’s standing room only at @WinshipAtEmory combined GYN onc and surg onc journal club as we refine our evidence-based #HIPEC protocol for #ovariancancer patients at Emory @SusanModesitt @jscalici @s_illey @SethConcorsMD
1
18
844
Still beaming from the magic that was the @nycmarathon in the city I love so very much 🏃🏼‍♀️🏃🏼‍♀️🏃🏼‍♀️
1
2
27
1,132
My better half, Ryan Langdale of @TheChartisGroup, quoted in the @WSJ on consolidation in the cancer industry. wsj.com/health/pharma/why-dr…

Why Drug Distributors Are Buying Cancer Specialists

The big three drug distributors are going all in on oncology practices.

wsj.com
1
1
299
Excited to be named an early career new investigator by NRG oncology! Can’t wait to bring more of these #clinicaltrials to our patients at @WinshipAtEmory @EmoryGynOb nrgoncology.org/Home/News/Po…

NRG Oncology Awards 10 Fellows for the Early Career & New Investigator Mentored Fellowship Program...

nrgoncology.org
3
1
28
1,134
Our newest editorial is out now—bravo to #SENECA investigators for their collaborative effort. Excited to see what we can do with this database to improve our clinical care!
IJGC
@IJGConline
4 Sep 2024
#Editorial on #SENECA study @SENECAStudy @ bit.ly/3MA71Fm #SLNmapping #EndometrialCancer @Quique_ChC @ClinicaNavarra @JennyMueller @Doctor_Beryl @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @RParejaGineOnco @lchiv4 @annafagottimd @Frumovitz @HousseinELHAJJ3 @AinhoaMada @Jc_vilches @erodriguezglez @daggezmine @astraubhar #WeeklyPodcast #LeadArticle #IJGConline #Research #Prevention #Treatment #Diagnostic #GynCancer #GynOnc #WomenHealth #SoMe #SoMe4GynOnc
5
15
1,610
Had a wonderful time joining @TuftsObGynRes on behalf of @EmoryGynOb to kick off this year’s Tufts OB/GYN grand rounds and talking about #fertility in #endometrialcancer
2
15
867
Antibody drug conjugates are an exciting new therapy, but so far targeting folate receptor ovarian cancer is limited to high grade. Here, we show that low grade ovarian cancers have the same % of folate receptor positivity. Next up: see if these treatments benefit patients!
Team Ovary, Memorial Sloan Kettering Cancer Center@TeamOvary_MSK
8 Jul 2024
Wonderful new paper out from @Doctor_Beryl evaluating folate receptor alpha expression in low grade serous ovarian cancer. A biomarker-driven approach to treatment selection is promising. @TeamOvary_MSK @TeamEndo_MSK pubmed.ncbi.nlm.nih.gov/3894…
5
30
2,658
Beryl Manning-Geist, MD retweeted
Winship Cancer Institute of Emory University@WinshipAtEmory
27 Jul 2024
Newly arrived Winship gynecologic oncologist Beryl Manning-Geist, MD, kicks off the next session with a talk on targeted and hormone therapy options for treating low-grade epithelial ovarian cancer. #DDHO2024
3
16
1,052
Beryl Manning-Geist, MD retweeted
Winship Cancer Institute of Emory University@WinshipAtEmory
27 Jul 2024
A wonderful gynecologic cancer session comes to a close with a panel discussion and patient case presentation with all of our speakers. #DDHO2024
1
3
7
1,311
Thrilled to participate in the editorial process, learn from the greats @David_Cohn_MD and work to bring forward advancements in GYN cancer care!
@GynOncJnls
@gynoncjnls
15 Jul 2024
‼️ New editorial 📄 program initiative between @gynoncjnls and #BRIDGES 🌉 scholars 👏 @SGO_org @GYNCancer @GOG @David_Cohn_MD @Doctor_Beryl @MMAlHilli @sy_rachel @LAURAJMOULTON @DNasioudis
3
3
25
1,892
Podcast “debut” with @IJGConline on our work on ovarian preservation in patients with #endometrialcancer. Always a fun time with @pedroramirezMD and @JennyMueller_
MSKCC Team Uterus@TeamEndo_MSK
11 Jun 2024
What role does molecular subtyping play in guiding ovarian preservation in endometrial cancer❓❓Check this highly anticipated podcast by Dr. Mueller and @Doctor_Beryl @MSKCancerCenter #gyncsm #gyn
2
3
22
2,580
Thank you @IJGConline for featuring our study on caring for young patients with #endometrialcancer @TeamEndo_MSK
IJGC
@IJGConline
22 May 2024
#EditorsChoice Molecular and pathologic data to guide selection of patients with endometrioid #endometrialcancer for #ovarianpreservation 🖥️ bit.ly/3QLKFmV @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4 @Doctor_Beryl @RiosDoriaMD @leitaomd @aburustummd @TeamEndo_MSK
6
18
1,681
My “out of office” starting off a little differently than anticipated… All is well and first vacation in a year begins NOW. Great flight crew support and medical kit @Delta!
1
19
3,275
Excellent read by the talented @tsialater!
IJGC
@IJGConline
25 Apr 2024
Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in #gynecologic malignancies 🔍 bit.ly/449nbxq @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4
1
4
15
1,964
Amazing experience learning from and working with @ClaireFriedma19 @DmitriyZamarin — so much to still discover about the immune system and GYN cancer! Read all about our study in @NatureMedicine
Dmitriy Zamarin MD PhD@DmitriyZamarin
24 Apr 2024
Check out our new story out in @NatureMedicine today: a phase II study of nivolumab in dMMR/hypermutated gynecologic cancers together with my dear friend @ClaireFriedma19 . link.springer.com/article/10… brief summary (thread):
1
12
1,189
Moving the needle on fertility preservation in #endometrialcancer : molecular data can refine our approach!
Team Ovary, Memorial Sloan Kettering Cancer Center@TeamOvary_MSK
26 Mar 2024
Exciting new paper from @Doctor_Beryl and @JennyMueller_ showing that integration of molecular and pathologic data can enhance selection of candidates with endometrial cancer for ovarian preservation. @TeamEndo_MSK @TeamOvary_MSK pubmed.ncbi.nlm.nih.gov/3850…
1
2
22
2,642
Beryl Manning-Geist, MD retweeted
Angeles Secord@AngelesSecord
15 Mar 2024
SGO Bridges - Impressive ground-breaking research career building initiative!
4
18
2,082
Green is the new black 🍀🍀
IJGC
@IJGConline
19 Mar 2024
#2024SpecialIssue Indocyanine green and near infrared technology in the treatment of #GynCan ✳️ bit.ly/3T8ji71 @Doctor_Beryl @VanceBroach @leitaomd @AndreasObermair @zivanovicmd @aburustummd @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows @GynMe4
3
13
1,965
Hold for my upcoming #SGOBRIDGES phase II trial that moves raf/mek/fak inhibition hormonal blockade to the FRONT-LINE in low grade serous #ovariancancer Expected to start enrolling @MSKCancerCenter in the next few weeks 👍
Shannon Westin, MD, MPH, FASCO@ShannonWestin
17 Mar 2024
We have made progress in low grade serous #OvarianCancer - but we need to start considering moving these trials to the frontline - Great point Dr. Moore! #SGOMtg #gyncsm
3
5
28
3,105
Load more